[PDF] Top 20 Treatment of type 2 diabetes.

... prevalence of type 2 diabetes and the risk of severe side-effects of oral antidiabetic agents are markedly increased with aging, special focus should be put on the specific group ... Voir le document complet

... behalf of the REACH and REGAIN investigators a Institute of Clinical Trials and Methodology, University College London, London, UK; b Department of Endocrinology & Nutrition, Hospital de la Santa ... Voir le document complet

... administration of GLP-1 in cardiac insufficiency and myocardial infarction improves cardiac function by increasing left ventricular ejection fraction ...Administration of the DPP-4-resistant GLP-1 analog ... Voir le document complet

... the treatment of type 2 diabetes: a randomised, open-label, non-inferiority ...weeks of treatment. 69th Scientific Sessions of the American Diabetes ... Voir le document complet

... use of FDC may offer the advantage of reducing the number of tablets to be taken and thereby increase patient's adherence to therapy ...[24,25]. Of note, atorvastatin was successfully combined ... Voir le document complet

... Benoît Viollet, Louise Lantier, Jocelyne Devin-Leclerc, Sophie Hébrard, Chloé Amouyal, et al... Tar- geting the AMPK pathway for the treatment of Type 2 diabetes...[r] ... Voir le document complet

... oral treatment of type 2 diabetes ...independently of insulin, with the inhibition of SGLT2 reducing renal reabsorption of glucose and increasing excretion ... Voir le document complet

... cotransporter type 2 (SGLT2) inhibitors (gliflozins), [6] glucagon-like peptide-1 receptor agonists (GLP-1 RAs), [7] and ...selection of second-line agents and a similar approach may be used when ... Voir le document complet

... abundance of co- morbidities, including type 2 diabetes ...modifications of the intestinal tract, is to date the most successful treatment for ...60% of patients even ... Voir le document complet

... including type 2 diabetes mellitus [12] and obesity, where training induced an increase in size and content of mitochondria [9] and enhanced mitochondrial fatty acid oxidation ...improvement ... Voir le document complet

... hyperactivation of the EC tone in obesity. Since the early 1990s, a number of genetic polymorphisms in the genes and proteins of the EC system have been characterized ...role of genetic ... Voir le document complet

... on 2 Jun 2020 HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or ... Voir le document complet

... level of evidence from interventional studies is much more important than that of obser- vational or cross-sectional ...use of significant VTD supplementation to achieve potential benefits in T2DM, ... Voir le document complet

... with type 2 ...results of earlier studies, an epidemiological study cannot show a causal relation, and such an observational database does not provide the detailed information that is available in a ... Voir le document complet

... measurement of AGE and it may be influenced by other fluorophores in the skin; neverthe- less, SAF does correlate with pentosidine, a common AGE, in skin ...with type 2 diabetes, and further ... Voir le document complet

... presence of microalbuminuria [ 9 ]. By analogy, the indication of ACE inhibi- tors in T2DM patients with albuminuria is now largely adopted, even in absence of hypertension but presence of ... Voir le document complet

... ratio of DAGH to TAGH activity, suggesting incomplete TAG hydrolysis ...muscle of obese insulin- resistant men compared with the lean group, but rather a 30% ...development of skeletal muscle insulin ... Voir le document complet

... (m 2 )], waist circumference (cm), systolic and diastolic blood pressure (mm Hg), HDL- and LDL-cholesterol (mmol/L), triglycerides (mmol/L), current smoking (yes/no), alcohol consumption (none, 1 to 3 units per ... Voir le document complet

... letter of the distinguished colleagues, Andre Scheen and Luc Van Gaal, and the opportunity to ...potential of rimonabant, the first representative of a new class of drugs, the CB1-receptor ... Voir le document complet

... induces type 2 diabetes at adulthood in male mice Hanna Ilchmann, Maiwenn Olier, Corinne Lencina, Sandrine Ellero-Simatos, Michèle Nankap, Ambre Riba, Caroline Sommer, Hervé Guillou, Laurence ... Voir le document complet